Physician profile
David Clark
NPI 1265433940
$1,056.55
in general payments reported to CMS, 2019-2025
13 companies · $138 in 2025
The $138 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $84.22 · 2021: $69.78 · 2022: $250 · 2023: $72.34 · 2024: $312 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $219.03 | 2022-2023 | Infinity |
| Sk Life Science, INC. | $189.72 | 2020-2022 | |
| Csl Behring | $188.96 | 2024-2025 | Hizentra |
| Stryker Corporation | $119.52 | 2024 | |
| Emd Serono, INC. | $98.41 | 2019-2020 | |
| Kedrion Biopharma, INC. | $71.80 | 2024-2025 | Albuked, Rhogam Ultra-Filtered Plus, Kedrab |
| Grt US Holding, INC. | $50.92 | 2020 | |
| Neurocrine Biosciences, INC. | $42.64 | 2019-2025 | |
| Pfizer INC. | $24.42 | 2024 | |
| Lilly USA, LLC | $18.95 | 2024 | Amyvid |
| Strongbridge US INC. | $12.58 | 2019 | |
| Medtronic USA, INC. | $10.95 | 2019 | |
| Travere Therapeutics, INC. | $8.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.